Junkal Garmendia

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 14

Top Topics

Escherichia Coli

Antimicrobial Resistance

Top Venues

Nanomedicine (London, England)

Microbial biotechnology

Microbiology spectrum

ACS infectious diseases

This page only lists publications with an associated author ORCID identifier.

Publications

Eva María Arroyo-Urea, María Lázaro-Díez, Junkal Garmendia, Fernando Herranz, Ana González-Paredes
Lipid-based nanomedicines for the treatment of bacterial respiratory infections: current state and new perspectives. Nanomedicine (London, England) (2024)
Junkal Garmendia, Pilar Cebollero-Rivas
Environmental exposures, the oral-lung axis and respiratory health: The airway microbiome goes on stage for the personalized management of human lung function. Microbial biotechnology 17 (6) (2024)
Junkal Garmendia, Pilar Cebollero-Rivas
Environmental exposures, the oral-lung axis and respiratory health: The airway microbiome goes on stage for the personalized management of human lung function. Microbial biotechnology 17 (6) (2024)
Eva María Arroyo-Urea, María Lázaro-Díez, Junkal Garmendia, Fernando Herranz, Ana González-Paredes
Lipid-based nanomedicines for the treatment of bacterial respiratory infections: current state and new perspectives. Nanomedicine (London, England) 19 (4) (2024)
Eva María Arroyo-Urea, María Lázaro-Díez, Junkal Garmendia, Fernando Herranz, Ana González-Paredes
Lipid-based nanomedicines for the treatment of bacterial respiratory infections: current state and new perspectives. Nanomedicine (London, England) 19 (4) (2024)
Junkal Garmendia, Pilar Cebollero-Rivas
Environmental exposures, the oral-lung axis and respiratory health: The airway microbiome goes on stage for the personalized management of human lung function. Microbial biotechnology 17 (6) (2024)
Eva María Arroyo-Urea, María Lázaro-Díez, Junkal Garmendia, Fernando Herranz, Ana González-Paredes
Lipid-based nanomedicines for the treatment of bacterial respiratory infections: current state and new perspectives. Nanomedicine (London, England) 19 (4) (2024)
Begoña Euba, Celia Gil-Campillo, Javier Asensio-López, Nahikari López-López, Emel Sen-Kilic, Roberto Díez-Martínez, Saioa Burgui, Mariette Barbier, Junkal Garmendia
In Vivo Genome-Wide Gene Expression Profiling Reveals That Haemophilus influenzae Purine Synthesis Pathway Benefits Its Infectivity within the Airways. Microbiology spectrum (2023)
Beatriz Rapún-Araiz, Ioritz Sorzabal-Bellido, Javier Asensio-López, María Lázaro-Díez, Mikel Ariz, Carlos Sobejano de la Merced, Begoña Euba, Ariadna Fernández-Calvet, Ivan Cortés-Domínguez, Saioa Burgui, Alejandro Toledo-Arana, Carlos Ortiz-de-Solórzano, Junkal Garmendia
In vitro modeling of polyclonal infection dynamics within the human airways by Haemophilus influenzae differential fluorescent labeling. Microbiology spectrum (2023)
Nahikari López-López, David San León, Sonia de Castro, Roberto Díez-Martínez, Manuel Iglesias-Bexiga, María José Camarasa, Margarita Menéndez, Juan Nogales, Junkal Garmendia
Interrogation of Essentiality in the Reconstructed Haemophilus influenzae Metabolic Network Identifies Lipid Metabolism Antimicrobial Targets: Preclinical Evaluation of a FabH β-Ketoacyl-ACP Synthase Inhibitor. mSystems 7 (2) (2022)
Irene Rodríguez-Arce, Xabier Morales, Mikel Ariz, Begoña Euba, Nahikari López-López, Maider Esparza, Derek W Hood, José Leiva, Carlos Ortíz-de-Solórzano, Junkal Garmendia
Development and multimodal characterization of an elastase-induced emphysema mouse disease model for the COPD frequent bacterial exacerbator phenotype. Virulence 12 (1) (2022)
Juan Nogales, Junkal Garmendia
Bacterial metabolism and pathogenesis intimate intertwining: time for metabolic modelling to come into action. Microbial biotechnology (2021)
María A Campanero-Rhodes, Ioanna Kalograiaki, Begoña Euba, Enrique Llobet, Ana Ardá, Jiménez-Barbero Jesús, Junkal Garmendia, Dolores Solís
Exploration of Galectin Ligands Displayed on Gram-Negative Respiratory Bacterial Pathogens with Different Cell Surface Architectures. Biomolecules 11 (4) (2021)
Nahikari López-López, Begoña Euba, Julian Hill, Rabeb Dhouib, Lucı A Caballero, José Leiva, Jennifer Hosmer, Sergio Cuesta, José Ramos-Vivas, Roberto Díez-Martínez, Horst Joachim Schirra, Lars Mathias Blank, Ulrike Kappler, Junkal Garmendia
Haemophilus influenzae Glucose Catabolism Leading to Production of the Immunometabolite Acetate Has a Key Contribution to the Host Airway-Pathogen Interplay. ACS infectious diseases 6 (3) (2020)